Saturday 17 October 2026
Export AUNA’s income statement to Excel — free account
Auna S.A.
AUNA Healthcare Medical Care Facilities
Auna S.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.27% from fiscal 2024. In the quarter to June 2026, revenue grew 20.5%, EPS fell 61.3%, free cash flow grew 121.1% and total debt rose 7.31%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
5.32
0.02
+0.38%
Follow AUNA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+7 more quarters Free account |
9.46 | 13.67 | 21.19 | 73.29 |
P/S ratio |
0.42 | 0.30 | 0.31 | 0.28 | |
P/FCF ratio |
3.74 | 2.48 | 2.31 | 1.79 | |
P/Operating CF |
8.91 | 5.94 | 7.76 | 4.92 | |
P/B ratio |
0.97 | 0.73 | 0.71 | 0.63 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.21 | 1.04 | 1.07 | 0.97 | |
EV/EBITDA |
6.05 | 5.56 | 5.79 | 5.46 | |
EV/Operating CF |
8.12 | 6.88 | 6.66 | 5.35 | |
EV/FCF |
10.76 | 8.69 | 8.03 | 6.24 | |
Quick Ratio |
0.70 | 0.84 | 0.84 | 0.85 | |
Current Ratio |
0.90 | 1.11 | 1.09 | 1.08 | |
Net Debt/EBITDA |
15.08 | 16.27 | 16.35 | 15.10 | |
Debt/Assets |
49.76% | 49.69% | 49.23% | 47.44% | |
Debt/Equity |
2.00 | 2.05 | 1.97 | 1.80 | |
Asset Turnover |
0.60 | 0.63 | 0.62 | 0.64 | |
Operating CF/Net income |
4.10 | (3.37) | 26.71 | 8.96 | |
Capex/Depreciation |
(0.51) | (0.64) | (0.67) | (0.59) | |
Interest Coverage |
1.43 | 0.51 | 1.31 | 1.37 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
23.18% | 24.33% | 23.47% | 23.69% | |
Intangible Assets out of Total Assets |
0.38 | 0.37 | 0.37 | 0.37 | |
Share Based Compensation of Revenue |
0.27% | 0.23% | 0.16% | 0.24% | |
Graham Net Nets |
(2.09) | (2.84) | (2.78) | (2.86) | |
Graham Number |
10.54 | 7.37 | 6.75 | 3.58 | |
Earnings Yield |
10.57% | 7.32% | 4.72% | 1.36% | |
Free Cash Flow Yield |
26.76% | 40.40% | 43.23% | 55.76% | |
Revenue per Share |
4.28 | 4.51 | 4.78 | 4.90 | |
Operating CF per Share |
0.75 | 0.83 | 0.71 | 1.04 | |
Capex per Share |
(0.10) | (0.12) | (0.14) | (0.12) | |
Free Cash Flow per Share |
0.65 | 0.71 | 0.57 | 0.92 | |
Cash per Share |
1.25 | 1.39 | 1.74 | 1.90 | |
Shareholders Equity per Share |
6.95 | 6.70 | 7.79 | 8.12 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.95 | 6.70 | 7.79 | 8.12 | |
Free Cash Flow |
48.17 | 52.73 | 41.63 | 67.96 | |
Working Capital |
(58.93) | 49.80 | 48.33 | 41.91 | |
Capital Expenditures |
(7.66) | (8.62) | (10.04) | (8.80) | |
Net Current Asset Value |
(1,036.78) | (1,034.61) | (1,113.33) | (1,078.00) | |
EV/EBIT |
7.80 | 7.29 | 7.58 | 7.20 | |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.02 | |
Price to Operating Income |
2.71 | 2.08 | 2.18 | 2.07 | |
| Other line items | |||||
Average Receivables |
283.32 | 274.48 | 302.99 | 304.73 | |
Average Payables |
249.17 | 271.88 | 285.06 | 292.62 | |
Average Inventory |
38.79 | 42.28 | 39.77 | 40.74 | |
Average Assets |
1,982.77 | 1,967.42 | 2,090.35 | 2,115.16 | |
Average Common Equity |
479.21 | 464.08 | 509.02 | 544.38 |
Columns are period end dates